Precigen
PGEN
169 hedge funds and large institutions have $182M invested in Precigen in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 61 reducing their positions, and 21 closing their positions.
96% more call options, than puts
Call options by funds: $475K | Put options by funds: $242K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
2% less funds holding
Funds holding: 173 → 169 (-4)
3.88% less ownership
Funds ownership: 69.34% → 65.46% (-3.9%)
30% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 61
40% less capital invested
Capital invested by funds: $303M → $182M (-$121M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.12M |
| 2 |
BlackRock
New York
|
+$760K |
| 3 |
Renaissance Technologies
New York
|
+$453K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$326K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$255K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4M |
| 2 |
Millennium Management
New York
|
-$3.13M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.25M |
| 4 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$1.18M |
| 5 |
Two Sigma Investments
New York
|
-$918K |
PGEN Hedge Fund Activity: Q2 2022 in Review
169 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q2 2022, worth a combined $182M — down 40% from $303M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of PGEN and 20 opened new positions — a net loss of 1 holder — while 61 trimmed existing stakes and 43 added.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $1.12M. The largest seller was Vanguard Group, cutting an estimated $4M.
- 169 institutional investors held Precigen (PGEN) as of Q2 2022, down from 173 in Q1 2022.
- Funds reported $182M of Precigen stock for Q2 2022, down 40% quarter-over-quarter.
- 20 funds opened new Precigen positions in Q2 2022 and 21 closed out, a net change of -1 holder.
- The largest Precigen buyer in Q2 2022 was Jacobs Levy Equity Management, an estimated $1.12M added.
- The largest Precigen seller in Q2 2022 was Vanguard Group, an estimated $4M sold.
Based on aggregated 13F filings for Q2 2022.